CN Patent

CN110746403A — 地匹福林盐酸盐的稳定型晶体及其结晶化方法

Assigned to Dapeng Pharmaceutical Industry Co Ltd · Expires 2020-02-04 · 6y expired

What this patent protects

本发明涉及地匹福林盐酸盐的稳定型晶体及其结晶化方法。本发明的课题在于得到5‑氯‑6‑[(2‑亚氨基吡咯烷‑1‑基)甲基]嘧啶‑2,4(1H,3H)‑二酮一盐酸盐的稳定型晶体,作为其解决手段,提供一种5‑氯‑6‑[(2‑亚氨基吡咯烷‑1‑基)甲基]嘧啶‑2,4(1H,3H)‑二酮一盐酸盐的晶体,以粉末X射线衍射的衍射角(2θ±0.1°)表示,在11.6°、17.2°、17.8°、23.3°、27.1°和29.3°处观察到特征峰。

USPTO Abstract

本发明涉及地匹福林盐酸盐的稳定型晶体及其结晶化方法。本发明的课题在于得到5‑氯‑6‑[(2‑亚氨基吡咯烷‑1‑基)甲基]嘧啶‑2,4(1H,3H)‑二酮一盐酸盐的稳定型晶体,作为其解决手段,提供一种5‑氯‑6‑[(2‑亚氨基吡咯烷‑1‑基)甲基]嘧啶‑2,4(1H,3H)‑二酮一盐酸盐的晶体,以粉末X射线衍射的衍射角(2θ±0.1°)表示,在11.6°、17.2°、17.8°、23.3°、27.1°和29.3°处观察到特征峰。

Drugs covered by this patent

Patent Metadata

Patent number
CN110746403A
Jurisdiction
CN
Classification
Expires
2020-02-04
Drug substance claim
No
Drug product claim
No
Assignee
Dapeng Pharmaceutical Industry Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.